Karen Dawes

Karen Dawes discloses dealings in Medicenna Therapeutics Corp. to SEDI. Between 24 September 2019 and 29 November 2024, the trades on record add up to 6 filings.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 4 December 2024 with an option exercise in Medicenna Therapeutics Corp. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.